Top FDA Staff Are Pushing Review Teams To Be Comfortable With Regulatory Flexibility

 
• By Sarah Karlin-Smith

Senior leadership in the FDA’s drugs, biologics and devices centers want reviewers to feel more comfortable taking risks in product approvals, but may need more concrete examples of regulatory flexibility's success to convince them.

man in suit pushing big boulder
FDA leadership is pushing staff to be more comfortable taking risks. • Source: Shutterstock

More from Approval Standards

More from Pathways & Standards